Jefferson may buy Temple University Health cancer center
Jefferson Health signed an exclusive agreement to consider buying Temple University Health System’s Fox Chase Cancer Center. The Philadelphia-based organizations have 90 days to determine whether the acquisition will improve care for cancer patients in the region and fit their strategic goals. The due diligence period will include evaluation of the sale of Temple’s interest in Health Partners Plans, a managed-care operator.
The 100-bed Fox Chase Cancer Center would pair nicely with Jefferson’s Sidney Kimmel Cancer Center, Dr. Stephen Klasko, president of Thomas Jefferson University and CEO of Jefferson Health, said in prepared remarks.
If the organizations approve the deal and it clears federal and state regulators’ review, Jefferson and Temple would enter into a long-term oncology-related academic affiliation agreement that would give Temple residents, fellows and students access to additional academic and research resources.